March 2026 FDA Recall Pantoprazole Sodium by Hetero Labs Limited (unit V) (D-0484-2026 - Discoloration)

This Class II drug recall was voluntarily initiated by Hetero Labs Limited (unit V) on March 26, 2026 for the product Pantoprazole Sodium. The FDA reported the reason for recall as discoloration. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0484-2026

Reason for Recall
Discoloration: Firm received five (5) complaints stating that, "Tablets discolored darker than normal and have lighter-colored spots."
Initiated
03-26-2026
Reported
04-29-2026
Quantity
4,740 1,000-count bottles.

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Hetero Labs Limited (Unit V)
Nationwide in the USA.
Pantoprazole Sodium, Delayed-Release Tablets, USP, 40 mg, 1000-count bottle, Rx only, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, By: Hetero, Hetero Labs Limited, Unit V, Polepally, Jadcherta, Mahabubager-509 301, India, NDC 31722-713-10

Batch or Lot Expiration Information

Batch# FD253967, Exp Date: 06/26/2027